SCHEMBL14280073

SCHEMBL14280073

COc1ccc(-c2n[nH]c(C(C)(C)C)c2C(C)(C)C)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.51
PDE4B Q07343 3/20 0.51
PDE4C Q08493 3/20 0.51
PDE4D Q08499 3/20 0.51
KDM4E B2RXH2 6/20 0.48
HSD17B10 Q99714 3/20 0.48
ALDH1A1 P00352 5/20 0.44
KMT2A Q03164 2/20 0.43
LMNA P02545 3/20 0.42
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ADORA1 P30542 1/20 0.42
MAPT P10636 3/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.39
MPI P34949 1/20 0.39
GFER P55789 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14306707 0.82 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL22327923 0.70 KDM4E (0.50) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL6055066 0.70 KDM4E (0.50) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL6477699 0.68 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL14544751 0.68 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL11683985 0.68 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL14427216 0.68 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL5373302 0.67 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL8840880 0.67 PDE4A (0.67) PDE4AKDM4EHSD17B10ALDH1A1KMT2A
SCHEMBL3846446 0.66 PDE4A (0.49) PDE4APDE4BPDE4CPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080027228-A1 Substituted thioacetamides CEPHALON, INC. (US) 2008-01-31 US disclosed
US-7268132-B2 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder CEPHALON, INC. (US) 2007-09-11 US disclosed
US-RE39575-E1 Substituted thioacetamides CEPHALON, INC. (US) 2007-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027228-A1 Substituted thioacetamides TST, TTR, TBCA PDE4A 2911/4885PDE4B 3386/4885PDE4C 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.